NGS in Gallbladder Cancer and Response to Treatment
Launched by BANARAS HINDU UNIVERSITY · May 31, 2022
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how specific genetic changes in gallbladder cancer can affect how well patients respond to different treatments. Researchers believe that understanding these genetic differences could help them create more personalized treatment plans for patients with gallbladder cancer, similar to what has been done for other types of cancer. The trial is currently looking for participants, specifically patients who have been diagnosed with gallbladder cancer and have not yet started any treatment.
To be eligible for this trial, participants must be adults aged 18 or older who have a confirmed diagnosis of gallbladder cancer. Unfortunately, pregnant or breastfeeding women cannot participate. If you join the study, you can expect to undergo tests that analyze the genetic makeup of your tumor, which may help inform the best treatment options for you. This trial aims to better understand how genetics play a role in treatment responses for gallbladder cancer, which could lead to improved care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Treatment naïve patients with histologically proven carcinoma of the gallbladder.
- Exclusion Criteria:
- • No histological evidence of malignancy
- • Pregnant and lactating women
About Banaras Hindu University
Banaras Hindu University (BHU) is a prestigious institution located in Varanasi, India, renowned for its commitment to excellence in education and research across various disciplines, including medicine and health sciences. As a clinical trial sponsor, BHU leverages its robust academic infrastructure and multidisciplinary expertise to advance innovative research aimed at improving healthcare outcomes. The university fosters collaboration between researchers, healthcare professionals, and community stakeholders to ensure the ethical conduct and scientific rigor of its clinical trials, ultimately contributing to the advancement of medical knowledge and the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Varanasi, Up, India
Patients applied
Trial Officials
Manoj Pandey, Ms, PhD
Principal Investigator
Banaras Hindu University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials